Immunotherapy has revolutionized the field of oncology, offering hope in the face of previously untreatable malignancies. This article aims to elucidate the principles of immunotherapy, its applications, and potential side effects.
Immunotherapy harnesses the power of the body's immune system to fight cancer. It works by either stimulating the immune system to attack cancer cells or providing it with synthetic immune system proteins. Key strategies include checkpoint inhibitors, CAR T-cell therapy, and cancer vaccines.
The scope of immunotherapy extends across various malignancies. It has proven effective in treating melanoma, lung, kidney, bladder, head and neck cancers, and certain types of lymphoma. Research is ongoing to expand its applicability to other cancer types.
Checkpoint inhibitors work by blocking immune checkpoints, proteins that prevent immune cells from attacking normal cells. By inhibiting these checkpoints, these drugs allow the immune system to recognize and attack cancer cells. Examples include pembrolizumab and nivolumab.
Chimeric Antigen Receptor (CAR) T-cell therapy involves modifying a patient's T cells to express receptors that bind to specific proteins on cancer cells, enhancing their ability to seek out and destroy the malignancy. This therapy has shown promising results in treating certain types of leukemia and lymphoma.
Cancer vaccines, like the HPV vaccine, aim to prevent cancer by stimulating the immune system to attack specific viruses that cause cancer. Therapeutic cancer vaccines, on the other hand, are designed to treat existing cancers by triggering the immune system to recognize and attack cancer cells.
While immunotherapy offers significant benefits, it also carries potential side effects, often resembling autoimmune reactions, as the immune system becomes more active. These can range from mild fatigue and fever to severe lung inflammation and endocrine disorders.
Immunotherapy represents a significant breakthrough in the treatment of many cancers. By understanding its principles, applications, and potential side effects, physicians can better guide their patients through the complexities of cancer treatment.
1.
More evidence links physical activity with improved cancer survival
2.
Base-edited T-cell therapy offers additional hope for treating resistant leukemia.
3.
Ultrasound bras; HPV and thyroid cancer; language minimizing adverse events.
4.
In schizophrenia, sexual dysfunction is frequent.
5.
Nanoparticle vaccine prevents multiple cancers and stops metastasis in mice
1.
The Role of Calcium Corrections in Accurate Blood Test Results
2.
Clonal Hematopoiesis and Healthy Aging: Insights, Mechanisms, and Clinical Relevance
3.
Hematopoietic Stem Cell Fitness Biomarkers: Clinical Relevance and Emerging Paradigms
4.
Cemiplimab: A Revolutionary Drug For Treating Cancer
5.
Unlocking the Potential of Hemin: A Novel Approach to Health and Wellbeing
1.
International Conference on Oncology, Cardiology and Critical Care Policy
2.
International Conference on Innovations in Critical Care for Oncology and Cardiology
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Cancer Nursing and Hematology Support
1.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part II
2.
The Comprehensive Impact of CDK4/6 Inhibition in HR+/HER2- Metastatic Breast Cancer: Insights from PALOMA-2.
3.
Blood Clotting Disorders Explained
4.
Efficient Management of First line ALK-rearranged NSCLC - Part II
5.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part VIII
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation